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Introduction: Both ventricular and parenchymal devices are available for measurement of intracranial pressure
(ICP). The Hummingbird® Synergy Ventricular System is a novel device allowing multi-parametric neurological
monitoring, including both ventricular and parenchymal ICP. The purpose of this study is to compare the
congruence of the device’s ventricular and parenchymal ICP readings.
Methods: This single-center, quantitative, interventional study compared parenchymal and ventricular ICP readings from
35 patients with the Hummingbird® System. If a difference of > ± 3 mmHg existed between an individual patient’s
parenchymal and ventricular values, progressive intervention strategies were applied to correct identified issues.
Results: From a total of 2,259 observations, statistical analysis revealed congruence (within ±0-3 mmHg) of 93% of
readings comparing parenchymal and ventricular ICP. Of the observations requiring intervention, 58% involved the
parenchymal component, 30% involved the ventricular component, and 12% involved both components. Following
prescribed interventions, 98% of readings became congruent (within ±0-3 mmHg). The adjusted mean difference
between the two methods was −0.95 (95% CI: −0.97,-0.93) mmHg and all mean ICP readings fell between −2 and
2 mmHg.
Conclusion: The Hummingbird® Synergy Ventricular System demonstrates congruence between ventricular and
parenchymal ICP measurements within accepted parameters. Interventions required to realign parenchymal and
ventricular readings serve as reminders to clinicians to be vigilant with catheter/cable connections and to maintain
appropriate positioning of the ventricular drainage system. The results of this study support the recommendation to
use the parenchymal ICP component for routine ICP monitoring, allowing dedication of the ventricular catheter to
drainage of cerebrospinal fluid (CSF).
Keywords: Parenchymal ICP; Ventricular ICP; Intracranial pressure; External ventricular drain; Cerebrospinal fluid;
Neurocritical care; Traumatic brain injury; Subarachnoid hemorrhage; InnerSpace Neuro Solutions, Inc;
Hummingbird Synergy Ventricular SystemBackground
ICP monitoring and associated waveforms
Prevention and control of increased ICP and maintenance
of cerebral perfusion pressure (CPP) are fundamental
therapeutic goals for critically ill neuroscience patients
(Smith 2008). Both intraventricular and intraparenchymal
devices are widely used in clinical practice for measuring* Correspondence: tmberlin@verizon.net
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in any medium, provided the original work is pICP. These devices are resource-intensive and carry
small but significant risks of infection and hemorrhage
(Frattalone and Stevens 2011). ICP monitoring devices
measure the sum of the pressures exerted within the cra-
nium by blood, brain, and cerebrospinal fluid (Littlejohns
and Bader 2008). They also transmit a waveform, repre-
senting the pressure pulse wave being transmitted into the
intracranial compartment by systemic hemodynamics.
Changes in brain compliance can be seen as alterations in
the normal waveform pattern. ICP waveform morphology
should be considered when assessing reliability of ICPOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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in which it is placed, and the length of time implanted
influence device functionality, accuracy, and incidence of
complications (Littlejohns and Bader 2008).
Ventricular ICP monitoring
Historically, the “gold standard” of ICP monitoring has
been via surgical insertion of a catheter into the ventricle
of the brain (Brean et al. 2006; Schimpf 2012). The
ventricular catheter is attached to a fluid-filled external
drainage system and, with application of a fluid-filled
transducer, is capable of monitoring ICP as well as
draining cerebrospinal fluid (CSF) as a therapeutic
measure (Zhong et al. 2003; Brain Trauma Foundation
2007). External ventricular drainage systems (EVDs)
allow only one mode of operation at a time. By manipulat-
ing stopcocks, EVDs can be configured to either monitor
ICP or drain CSF, but not perform both simultaneously
(Zhong et al. 2003).
For accurate monitoring of ICP via the EVD system,
the mounted transducer must be positioned and main-
tained at the level of the foramen of Monroe or, ana-
tomically, the external auditory meatus (EAM) (Zhong
et al. 2003). The accuracy of ICP readings therefore be-
comes dependent upon patient positioning in relation
to the transducer (Zhong et al. 2003; Brain Trauma
Foundation 2007). Accuracy of readings also depends
upon periodically opening the transducer to atmos-
pheric pressure and returning it to a zero reference
point (Schimpf 2012). Hospital protocols differ in the
frequency with which EVDs need to be zeroed, but the
zeroing procedure typically occurs during each patient
care shift, following patient transport, and as a trouble-
shooting measure when ICP readings or associated
waveforms are in question. With each zeroing, the
transducer must be exposed to atmosphere, necessitat-
ing a break in the sterile integrity of the system through
opening of stopcocks and port caps.
Use of the ventricular catheter for ICP monitoring re-
quires continuous nursing observation and intervention
to maintain appropriate patient positioning for accurate
monitoring (Littlejohns and Bader 2008). With a ven-
tricular catheter, CSF drainage must be periodically
interrupted to obtain ICP readings. Patients with limited
intracranial compliance may not tolerate interruption of
CSF drainage, even for short periods of time (Vender
et al. 2011).
Complications related to ventricular catheters include
1%-10% risk of infection and 1%-2% risk of bleeding
(Littlejohns and Bader 2008). Ventricular catheters may
be difficult to place when there is compression or shift
of the ventricles. In cases of a misplaced catheter, the
ICP waveform may be dampened and the ICP values
inaccurate (Zhong et al. 2003).Parenchymal ICP monitoring
Parenchymal ICP monitoring involves placement of a
fiberoptic, strain-gauge, or air bladder (pneumatic) device
within the brain tissue. While parenchymal monitoring
devices do not allow drainage of CSF, their ICP monitor-
ing accuracy is reliable, second only to intraventricular
monitoring (Zhong et al. 2003). Parenchymal monitoring
devices require calibration and zeroing only once before
insertion. Accuracy of readings is not dependent upon
patient positioning in relation to the transducer (Zhong
et al. 2003; Brain Trauma Foundation 2007). However,
without the ability to recalibrate the sensor in situ, paren-
chymal devices are subject to varying degrees of zero drift
over time (Brain Trauma Foundation 2007; Lescot et al.
2011). Complications include infection and bleeding
(2%), although the incidence is lower with these de-
vices compared to ventricular catheters (Littlejohns
and Bader 2008).
Comparing ventricular and parenchymal ICP monitoring
There is precedence for comparison of ventricular and
parenchymal ICP, yet it is unclear if ventricular and
parenchymal pressure differences are expected. Both
positive and negative differences are reported by studies
comparing ventricular and parenchymal ICP. Review of
literature reveals a comparison study of the Spiegelberg
parenchymal transducer and ventricular fluid pressure.
Utilizing an air bladder technology for parenchymal ICP
monitoring, this study showed good agreement between
the readings from the Spiegelberg transducer with those
from the ventricular drain (Chambers et al. 2001).
Brean et al. (2006) examined differences in pulse ampli-
tude and mean pressure when comparing simultaneous
parenchymal and ventricular ICP. Comparison of 218,589
simultaneous single ventricular/parenchymal wave pairs
showed marginal differences in pulse pressure amplitude,
providing no evidence of a pressure gradient between the
ventricular CSF and brain parenchyma (Brean et al. 2006).
A somewhat larger difference (expressed as a standard de-
viation of 6.8 mmHg) in mean ventricular/parenchymal
single wave pressures was attributed to hydrostatic pres-
sure differences between the distal end of the EVD and
the parenchymal ICP sensor (Brean et al. 2006). In a study
published in 2008, Eide compared parenchymal and ven-
tricular pressure readings in patients with documented
hydrocephalus and found that the ICP wave amplitude
was consistently higher within the ventricular CSF than in
the brain parenchyma (Eide 2008).
Lescot et al. (2011) compared ventricular ICP readings
to parenchymal readings obtained from both the Codman®
and the Pressio® systems. Although there was no statisti-
cally significant difference between readings from the par-
enchymal monitors, the parenchymal ICPs approximated
the ventricular CSF pressures by ±7 mmHg. The authors
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in different levels of the brain depending upon position of
the sensor tip and transducer levels. Vender et al. (2011)
recently compared hourly intraparenchymal and intraven-
tricular pressure readings in a small cohort of traumatic
brain injury patients. They found statistically similar pres-
sure measurements when comparing intraparenchymal to
intraventricular monitors.
According to the most recent Brain Trauma Foundation
guidelines for management of severe traumatic brain in-
jury (2007), “further improvement in ICP monitoring
technology should focus on developing multiparametric
ICP devices that can provide simultaneous measure-
ment of ventricular CSF drainage, parenchymal ICP, and
other advanced monitoring parameters” (Brain Trauma
Foundation 2007).
The Hummingbird® Synergy Ventricular System
The Hummingbird® Synergy Ventricular System (InnerSpace
Neuro Solutions, Inc.) provides uniquely integrated fea-
tures meeting these criteria and enabling both ventricular
drainage and parenchymal ICP monitoring. This cranial
access device also allows multi-parameter monitoring by
accommodating additional probes to monitor brain tissue
oxygen, cerebral perfusion, or cerebral microdialysis. For
the purpose of this study, the focus was on the device’s
capability for ICP monitoring and ventricular drainage
through parenchymal and ventricular components.
In addition to ventricular ICP, a sensor that resides along
the ventricular catheter, outside of the ventricle, transmits
parenchymal ICP using Air Coupled Transduction (ACT)
technology (InnerSpace Neuro Solutions, Inc 2010). ACT
technology senses pressure utilizing a proprietary air
bladder positioned in the parenchyma. In cases where
the ventricles of the brain are inaccessible, this provides
a benefit, wherein the catheter can be secured in the
parenchyma and used as a parenchymal ICP monitor.
This unique technology carries pressure waves from the
air column to a reusable transducer housed in the Air
Management System (AMS) on the terminal end of the
patient monitoring cable. When the AMS is manually cy-
cled, air is removed from the Hummingbird® ICP lumen/
sensor membrane and precisely replaced with 32 micro-
liters of air, effectively charging the system (InnerSpace
Neuro Solutions, Inc 2010). Indicator lights on the AMS
housing remind clinicians to re-charge the system every
eight hours to maintain the precise amount of air in the
system. With this technology, the leveling issues inherent
in fluid-coupled systems are eliminated, resulting in pre-
cise and positionally-insensitive measurements and an
artifact-free, high-fidelity waveform tracing. The AMS pa-
tient cable is zeroed from the patient monitor following
catheter insertion and initial setup. Re-zeroing is required
only as a troubleshooting method, or when the cablebecomes disconnected. Neither zeroing nor charging the
AMS causes a breach of the sterile integrity of the system.
The ability to periodically re-zero the system in situ elimi-
nates the issue of zero drift that is a hallmark of microsen-
sor parenchymal monitors.
Early anecdotal clinical experience of 47 patients util-
izing the Hummingbird® Synergy Ventricular System re-
vealed good agreement between ventricular and
parenchymal ICP readings and waveform morphologies.
Discrepancies in readings typically directed clinicians to
issues with the EVD, ranging from the presence of air
bubbles or organic matter in the transducer to errors in
leveling or a need to re-zero the fluid-coupled system.
InnerSpace Neuro Solutions, Inc., manufacturers of the
Hummingbird® Synergy Ventricular System, supports earl-
ier findings of Brean et al. (2006), by suggesting that ICP
readings from the parenchymal portion of the catheter may
differ from ventricular CSF pressure by ±0-3 mmHg due to
known hydrostatic pressure differences. In some instances
where parenchymal ICP readings were higher than ven-
tricular readings, there was radiographic evidence of
focal injury corresponding to potentially higher ICPs in
the region surrounding the parenchymal ICP sensor on
the catheter.
Chohan et al. (2014) published their institution’s five
year experience with use of the Hummingbird® Synergy
Ventricular System. In that study, of 275 devices, 251
(91%) were successfully placed on the first attempt, 4
(2%) on the second attempt, and 18 (7%) on >2 attempts.
In the literature, the rate of misplaced catheters ranges
from 6% to 45% (Chohan et al. 2014). The authors con-
cluded that the system can be placed safely and effectively
at the bedside or in the operating room and that it carries
a similar or favorable complication profile when compared
to other ventricular ICP monitoring systems (Chohan
et al. 2014).
With this study, the authors hope to show that the
Hummingbird® Synergy Ventricular System transmits par-
enchymal intracranial pressure (ICP) readings equivalent
to ventricular ICP readings within ±3 mmHg (as reported
by the manufacturer). Establishing congruence of readings
proves reliability of the parenchymal ICP component and
allows dedication of the ventricular catheter to cerebro-
spinal fluid drainage.
Results and discussion
To our knowledge, this study provides the first clinical
data on the accuracy of the Hummingbird® ICP technol-
ogy compared to standard ventricular ICP monitoring
technology. No clinical data have been previously available
to support the manufacturer’s claim of congruence of ICP
measurements within ±3 mmHg.
Between July 2011 and April 2012, a total of 50
Hummingbird® Synergy Ventricular Systems were inserted
Table 1 Patient demographics/characteristics
Sample size, n 35





Subarachnoid hemorrhage 19 (54)
Traumatic brain injury 15 (43)
Intracerebral hemorrhage 1 (3)
Device implant time (days), mean ± SD 6.9 ± 3.0
PAR placement with respect to injured brain, n (%)
Contralateral 26 (74)
Ipsilateral 9 (26)
PAR placement in tissue, n (%)
Healthy tissue 30 (86)
Affected tissue 2 (6)
Penumbral region 3 (9)
All ICP values (mmHg), range
PAR 0-42
EVD 0-40
Mean patient ICP values (mmHg), range
PAR 5-22
EVD 6-24
Total number of paired ICP readings1, n 2258
Number paired device readings per patient, range 8-127
Observations obtained with head of bed at 30°, n (%) 1884 (83)
1One EVD value in one subject was not obtained resulting in 2258 EVD and
2259 PAR readings.
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University of New Mexico Hospital, a university-based,
Level 1 Trauma Center in Albuquerque, New Mexico. Pa-
tients with radiographic confirmation of correct place-
ment of the ventricular catheter were included in the
study. Correct placement was defined as verification of
the tip of the catheter within the lateral ventricle and the
ICP sensing air bladder outside of the ventricle in the
brain parenchyma.
Fifteen patients were excluded from the study for vari-
ous reasons. Seven patients were excluded because the
device was not successfully placed in the ventricle of the
brain. In these cases, there was no ICP waveform or
reading associated with the ventricular catheter, therefore
comparison to intraparenchymal ICP was not possible.
Three patients were excluded because of difficulty with in-
sertion and suspected rupture of the parenchymal balloon.
There was no intraparenchymal waveform or ICP reading,
and comparison to ventricular ICP was not possible.
Three patients were excluded because of unavailability
of the investigator for study enrollment or data collec-
tion. Two patients were excluded because of death
within four hours of device insertion and inability of
investigator to collect data. As a result, 35 patients
were successfully enrolled.
Table 1 shows pertinent patient demographics and
characteristics. The mean age of patients in the study
was 52 years. The majority of subjects (54%) were female
and the most common medical diagnosis was subarach-
noid hemorrhage (54%). The mean device implant time
was 6.9 days with the majority of parenchymal air bladders
placed in healthy tissue (74%) on the contralateral side of
the injury (86%). Most (83%) ICP recordings were taken
with patients’ head of bed elevated to 30 degrees.
ICP recordings and interventions
Recordings of both ventricular and parenchymal ICP
readings obtained from patients with the Hummingbird®
Synergy Ventricular System yielded a total of 2,259 ob-
servations. Of these, 2,098 (93%) showed congruence
between external ventricular drain (EVD) and paren-
chymal (PAR) ICP readings within ±3 mmHg, there-
fore requiring no clinical intervention. Differences of
4–8 mmHg between measurements were observed in
167 (7%) readings, and differences ≥9 mmHg were
observed in 19 (<1%) readings, leaving a total of 186
observations requiring clinical investigation and possible
intervention. Because of patient care activities or changing
clinical situations, 161 incongruent events were addressed.
Table 2 shows the types of interventions required based
on the total number of observations. It also shows the
types of interventions involving the PAR component, the
EVD, or both, based on the number of events requiring
intervention.Following device assessment, a total of 177 primary in-
terventions were performed; 109 involved the PAR and
68 involved the EVD. As seen in Table 3, the most fre-
quent primary intervention for the PAR was recharging
the AMS, followed by zeroing the AMS and tightening
of connections. Using the EVD, the most frequent primary
intervention involved leveling the transducer, zeroing it,
and then flushing it. After primary intervention, 106 (60%)
comparison readings demonstrated congruence of ICP
values within ±3 mmHg. A total of 71 secondary interven-
tions were required and performed. The most frequently
used secondary PAR intervention was charging the AMS
(91%), whereas the most frequently used secondary EVD
intervention was zeroing the transducer (88%). Using
prescribed interventions, 98% of EVD and PAR readings
became congruent (within ±0-3 mmHg) following a sec-
ondary intervention. PAR and EVD reading agreement fol-
lowing primary and secondary intervention is displayed in
Table 4.
Table 2 Intervention types
Interventions required No intervention required PAR source intervention EVD source intervention Dual source intervention Total
n = 2098 n = 93 n = 49 n = 19 2259
93% 4% 2% 1% 100%
Intervention types based
on total required
PAR EVD Dual Total
n = 93 n = 49 n = 19 161
58% 30% 12% 100%
Interventions required based on the total number of observations. Of the total number of observations, 93% required no intervention, meaning that PAR and EVD
readings were congruent.
Intervention types based on total events requiring intervention. Of the total number of observations, 161 (7%) required intervention. Of these, the majority (58%)
of interventions required to attain congruence of PAR and EVD reading involved the PAR source.
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was 10.8 (SD = 3.9) mmHg, with a range of 5–22 mmHg.
The mean EVD ICP reading was 11.7 (SD = 3.8) mmHg
with a range of 6–24 mmHg. The overall mean difference
of the 2248 paired measurements was −1.0 (SD = 1.8)
mmHg, with PAR consistently lower than EVD. Mixed
linear modeling of the paired differences revealed a signifi-
cant effect for the repeated measures (all p < 0.05), as well
as for intervention, age, implant time, type of injury, the
order of the observations; and three interactions: implant
time × type of injury, implant time × order of observations,
and type of injury × order of observations. Related statis-
tics have been omitted as the aim is to show agreement
between measurements, not find predictive factors of the
differences. After adjusting for these covariates, the mean
difference between the two methods was well within
3 mmHg of each other [adjusted mean difference = −0.95
(95% CI: −0.97,-0.93) mmHg]. While the mean difference
between device measurements was not negligible, the dif-
ference was less than 1 mmHg. After fitting independent
mixed linear models for each of PAR and EVD with the
same covariates previously described, the adjusted mean
ICP for PAR was 10.8 mmHg (95% CI: 10.6,11.1 mmHg)
and for EVD was 11.8 mmHg (11.6,12.0 mmHg).
To further support our findings, we used the Bland-
Altman method (Bland and Altman 1999; Myles and
Cui 2007) as described in Methods – Statistical Analysis
to graphically present the agreement between the two ICP
measurement methods. Figure 1 presents the mean differ-
ence (bias) between PAR and EVD versus the mean of the
two methods along with the 95% limits of agreement
adjusted for the repeated measurements and covariatesTable 3 Most frequent primary interventions associated with
Primary interventions for PAR Recharging AMS
n = 56
51%
Primary interventions for EVD Leveling transducer
n = 61
90%mentioned above. This approach indicates agreement
when the difference between the measurements falls
between −3.5 and 1.7 mmHg. The data reported here
had no outliers beyond these 95% limits of agreement,
and all observations fell within ±3 mmHg as specified
by the manufacturer.
Limitations
Several limitations apply to this study. First, ICP com-
parisons were performed during an 8–10 hour period
each day when the Registered Nurse (RN) investigator
was present in the clinical environment. Therefore, the
data do not represent all measures within a 24-hour
period. Next, a second investigator was present to valid-
ate data collection results and interventions on the first
five subjects. This was done to ensure inter- and intra-
rater reliability and minimize bias. However, other than
verbal inter-rater agreement, no statistical reliability test-
ing was performed, and data were not collected for this
purpose. Finally, the need for intervention to improve
congruence of parenchymal and ventricular ICP may be
linked more to the skill level and experience of the bedside
nurse in managing device technology than to device cap-
ability. The level of nursing experience or skill mastery
was not considered in the study design.
Conclusion
The Hummingbird® Synergy Ventricular System demon-
strates congruence between parenchymal and ventricular
ICP measurements within accepted parameters. Interven-
tions required to realign PAR and EVD readings serve as
reminders to clinicians to be vigilant with catheter/cableeach ICP source
Zeroing AMS Tightening connections
n = 48 n = 5
44% 5%
Zeroing transducer Flushing transducer
n = 5 n = 2
7% 3%
Table 4 Agreement between parenchymal and ventricular





Number of Interventions Performed 177 71
Number of Readings Becoming
Congruent After Intervention Type
106 69
Percentage of Readings Becoming
Congruent After Intervention Type
60% 98%
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the ventricular drainage system. The results of this study
support the accuracy of parenchymal ICP readings and
their congruence with ventricular ICP readings obtained
from the Hummingbird® Synergy Ventricular System. The
results of this study also support the recommendation to
use the PAR ICP sensor for routine ICP monitoring,




There were no risks associated with this study. Patients
received standard of care for the intracranial monitoring
device and standard ICP management. Following expedited
review, study approval was obtained from the University of
New Mexico Human Research Review Committee (HRRC).
The requirements for informed consent and HIPAA
Authorization Addendum were waived.
Study design
For all subjects enrolled in the study, verification of
Hummingbird® Synergy Ventricular System placementFigure 1 Bland-Altman plot of the difference between mean PAR and
in each patient in the study. This shows that, on average, measurementswas confirmed by radiographic imaging via CT Scan.
This is standard of care for patients receiving this device.
Subjects did not undergo any additional radiographic
exams or diagnostic testing because of participation in
the study.
Data for direct comparison of ventricular and paren-
chymal ICP were gathered using a data collection tool
designed for this study. Parenchymal (PAR) and ven-
tricular (EVD) ICPs were recorded every one to two
hours (as indicated by clinical condition) for an inter-
val of 8 to 10 hours each day of the implant period dur-
ing which the RN investigator was clinically present.
Values were recorded with the patient at rest in a pos-
ition with the head of bed elevated at 30 degrees. If the
patient’s clinical condition contraindicated positioning
at 30 degrees, then the positioning determined to be
therapeutic for that patient was used and documented.
Parenchymal and ventricular waveforms were assessed
for adequacy and congruency. If the ventricular drain-
age system had been open to allow drainage of CSF,
then the drainage portion was closed, the transducer
accessed, and ICP recorded after a two-minute equili-
bration period.
The manufacturer reports an expected variance of paren-
chymal and ventricular ICP by ±0-3 mmHg. If parenchymal
and ventricular ICPs varied by more than ±3 mmHg,
the Hummingbird® System and EVD were examined
for issues that might contribute to inaccurate values or
poor waveform morphology. These issues include air
bubbles or organic matter in the EVD transducer, im-
proper leveling of the EVD with the EAM, cable malfunc-
tion, scheduled re-charging of Hummingbird® AMS, or
other reasons.mean EVD ICP measurements against the mean of PAR and EVD
from each method fell within ±3 mmHg of each other.
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Interventions within the scope of nursing practice were
performed by the RN investigator to correct identified
issues. The intervention strategy was based upon device
assessment and waveform morphology. Interventions for
the parenchymal sensor included the following: the
AMS was charged, the ACT ICP was zeroed, the con-
nections tightened, or the cable changed. Interventions
for the ventricular catheter included the following: the
EVD transducer was leveled or zeroed, the transducer
or tubing was flushed to clear out air bubbles, blood,
or debris, or the transducer or cable was changed. If
ICPs remained incongruent following a single inter-
vention, additional interventions were attempted. After
intervention(s) were performed, PAR and EVD ICPs
were re-recorded and the required intervention(s) docu-
mented. Waveform morphology was again assessed and
documented.
Statistical analysis
A power analysis was performed to determine the ad-
equate sample size necessary for determining whether
PAR and EVD ICP measurements were equivalent to
within ±3 mmHg of each other, as reported by the
manufacturer. Based on preliminary data, the mean (SD)
difference over the course of therapy was expected to be
approximately 2.0 (2.0) mmHg. Based on those assump-
tions, a sample size of n = 35 was required to obtain 95%
power to determine that the mean difference would fall
within the ±3 mmHg margin previously reported. The
power analysis was performed in PASS 11 (Hintze 2011).
Descriptive statistics were used to summarize the data.
The differences for PAR and EVD ICP measurements
were calculated at each time point for every subject and
the differences were assessed for normality. A linear
mixed model with unstructured covariance was fitted in
SAS PROC MIXED to the differences of paired PAR and
EVD ICP readings to account for the within-subject
variance of the repeated measures and adjust for the
following potential covariates: whether an intervention
was performed, type of injury, implant side, age, gen-
der, implant length of time, order of the observations,
and all two-way interactions. The adjusted mean differ-
ence and 95% confidence interval were calculated from
this model. A repeated measures multivariate analysis
of variance model was fitted to both EVD and PAR ICP
readings simultaneously and the same covariates as in
the first model were found to be statistically significant.
The adjusted mean estimates and their 95% confidence in-
tervals for PAR and EVD measurements were calculated
from this model.
The Bland-Altman method (Bland and Altman 1999)
for measuring agreement in unequal numbers of repli-
cates was used to calculate the 95% limits of agreementbetween the two ICP measurement methods. In general,
the limits of agreement are calculated as
d  1:96sd ð1Þ
where d is the mean difference of the methods and sd is
the sample standard deviation of d . When data fall within
these limits, the methods are generally considered to be in
agreement. Following their procedure, Bland and Altman
(1999) define the calculation of the square of sd (sample
variance of the mean difference) for repeated measures
with unequal replicates as
s2d ¼ Var d















where n is the number of subjects in the study, mPAR;i
and mEVD;i are the number of repeated measures for
each subject with each method, and s2PAR;w and s
2
EVD;w
are the within-subject variance estimates of PAR and
EVD, respectively. However, to better capture the vari-
ability due to the repeated measures and unequal repli-
cates, the calculations of s2PAR;w and s
2
EVD;w were
modified by adjusting for the between-subject variances
within EVD and PAR measurements, using a method
described by Myles and Cui (2007). This was accom-
plished by fitting two linear mixed models with unstruc-
tured covariance to each of PAR and EVD ICP with the
independent variables found to be significant from the
model of the paired ICP differences described above in
addition to a variable of the mean PAR-EVD ICP value
at each reading. From these models, the covariance par-
ameter estimates s2PAR;w and s
2
EVD;w were obtained and
applied to [2] for the calculation of the estimated vari-
ance of the difference for the 95% limits of agreement.
The square root of s2d was calculated and then
substituted into [1] and the limits were obtained. Statis-
tical significance was held at α = 0.05. All analyses were
performed in SAS version 9.4 (SAS Institute 2012) and
Stata 13/SE (Stata Corp 2014).
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